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Background: Disclosing a diagnosis of dementia is a key process involving people with dementia, 
carers, and healthcare professionals (HCPs) that can facilitate access to treatment and support. 
Receiving a diagnosis of dementia may represent a change in identity and loss of a planned-for 
future, resulting in an emotional impact for both people with dementia and carers. Delivering the 
diagnosis of dementia can be difficult and draining for HCPs.  
Methods: We conducted a systematic review that included studies which explored the experience of 
giving or receiving a diagnosis of dementia from the perspectives of people with dementia, carers, or 
HCPs. All study designs were eligible except for previous literature reviews. Findings were analysed 
thematically and grouped into categories, and then synthesised into a narrative review. The quality 
of all included studies was assessed.  
Results: Fifty-two studies were included in this review. Findings indicated that receiving a diagnosis 
is generally a negative process for people with dementia, carers, and HCPs and leaves carers in 
particular feeling uncertain over the prognosis and future of the person they care for. Disclosing a 
diagnosis of dementia is a difficult and complex process, for which formal training and guidance is 
lacking. Carers in particular would welcome more opportunity for realistic and hopeful discussions of 
the implications of receiving a diagnosis of dementia. 
 Conclusions: Changes in some aspects of disclosure, such as providing a truthful diagnosis to the 
person with dementia, have occurred over the last decade. A process approach involving pre-
diagnostic counselling and follow-up appointments could enable discussions regarding prognosis and 
the future, create opportunities to clarify the diagnosis, and reduce emotional burden on HCPs. 
There is a need for more objective evidence that considers the perspectives of all individuals 




Receiving a diagnosis of dementia is an important step for people with dementia because it 
facilitates access to interventions, and potential support from health and social services and third 
sector organisations (Robinson et al., 2015). Receiving a diagnosis may be an emotionally charged 
experience, representing a transition in identity for people with dementia and their carers requiring 
an emotional readjustment and reappraisal of their future (Robinson et al., 2011). The proportion of 
those developing symptoms of dementia who receive a diagnosis has increased in the UK 
(Abhayaratne et al., 2019) and internationally (World Health Organization., 2020), partly in response 
to policy changes (Department of Health, 2015), and due to greater awareness and acceptance of 
dementia. A recent systematic review (van den Dungen et al., 2014) using a pooled average based on 
9,065 respondents from 23 studies demonstrated that approximately 85% of people with cognitive 
impairment would wish to be a told a diagnosis if one were made. Knowledge of prognosis and 
illness trajectories enables people to plan and ensure their affairs are in order or undertake lifestyle 
changes (Woods et al., 2019). Typically, in developed countries, diagnosis disclosure occurs in 
secondary care settings, conducted by professionals such as psychiatrists, clinical psychologists, or 
specialist nurses. However, some diagnosis disclosures occur in primary care, delivered by a primary 
care physician. The time from developing awareness of cognitive changes to receiving a diagnosis 
varies across individuals, but can be a lengthy process; a delay of three years is not uncommon 
(Chrisp et al., 2011). The communication and delivery of the diagnosis requires careful management 
to account for a variety of reactions, needs and levels of understanding from both the person with 
dementia and carers accompanying them to the disclosure meeting (Bunn et al., 2012).  
 
There are differences between HCPs’ perceptions of best practice when disclosing a diagnosis of 
dementia and the perceptions of people with dementia or carers, which raises ethical dilemmas 
about how to respect these different needs (Dooley et al., 2015). An earlier literature review 
(Lecouturier et al., 2008) identified a list of best practice behaviours and combined this with a 
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qualitative exploration and consensus approach to identify eight categories of best practice for 
disclosure. These categories comprised preparing for disclosure, integrating family members, 
exploring the patient’s perspectives, disclosing the diagnosis, responding to the patient’s reactions, 
focusing on quality of life and well-being, planning for the future, and communicating effectively. 
Whilst comprehensive, this review is now over ten years old and the authors did not critically 
appraise the included research. Another review (Werner et al., 2013) covering a similar topic and 
time frame addressed a broad range of topics related to dementia diagnosis disclosure, but without 
a specific focus on which practices are typical and how they might be perceived. Given the recent 
policy initiatives around early diagnosis and changes in societal awareness of dementia over the last 
decade (Department of Health, 2015) an updated review of the evidence regarding disclosure from 
the perspectives of people with dementia, carers, and healthcare professionals (HCPs) is required.  
 
Objectives 
This review aimed to explore the experiences of giving or receiving a diagnosis of dementia. It 
identified common disclosure practices, challenges associated with disclosing the diagnosis, and 
needs of different individuals involved in the disclosure. It extended earlier work by including a 
systematic search strategy and a critical appraisal of the results using an established quality 
assessment tool, and went beyond describing the range of possible practices and behaviour to 




A search of the PubMed, CINAHL, and Web of Science databases was conducted on 31st October 
2018; updated on 7th February 2020. Reference sections of included papers were hand-searched to 
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identify further publications. The terms ‘dementia’ AND ‘diagnosi*’ were used to search titles and 
abstracts. A second search was conducted which combined these with the terms ‘disclosure’ OR 
‘best practice’, used to search in all fields. The study flowchart is shown in Figure 1. Due to the large 




Studies were included if they were written in English and provided information on delivering or 
receiving a diagnosis of dementia. All study types were eligible except for articles that only included 
a review of previous literature. Studies from the perspectives of HCPs, patients, and carers were all 
considered. The two primary reviewers (JY and MS) screened the titles, excluding articles that were 
not relevant, and then reviewed the abstracts. Full texts were retrieved if the title and abstract 
suggested that an aspect of delivering or receiving a diagnosis of dementia was explored. JY and MS 
conducted this task jointly, resolving differences in judgement through discussion and agreement.  
 
Data collection and synthesis 
Data were extracted using a table developed by JY and MS to capture the study details (Table 1). 
Initially, JY and MS extracted the data together to ensure consistency, before continuing to extract 
data independently and amalgamating tables once complete. As data were extracted, a number of 
similar ideas and issues were identified in the findings. These were collated in a separate document 
and added to by JY and MS until data extraction was complete. Similar findings were grouped to 
form thematic categories. These themes were refined and amalgamated where possible through 
discussion and during the writing of the narrative by the whole research team. Themes were 





Methodological quality was assessed by JY and MS using the Joanna Briggs Institute checklists 
(Aromataris and Munn, 2017). The corresponding checklists for each study design were used. A 
rating of methodological quality that was comparable across different designs was made by 
calculating the number of items endorsed on each checklist for each article and converting this into 
a percentage. Ten percent of the articles were sampled using a random number generator and 
assessed for quality by a third reviewer (AH). Reviewer scores were compared for consistency using 
a paired samples t-test. No significant differences were found (t(4)=2.33, p=.080), suggesting a 
robust quality assessment. 
 
Results 
Fifty-two studies were included. Main findings are summarised in Table 1. Findings are categorised 
under the following themes: content of the diagnosis disclosure; emotional impact; communication 
of the diagnosis; people involved; attitudes towards diagnosis disclosure; use of diagnostic tests and 
assessments; truth telling and deception; timeliness; and training and skills.  
 
(((Figure 1 about here))) 
(((Table 1 about here))) 
 
Quality assessment 
Quality assessment scores are shown in Table 1. Detailed assessments can be obtained on request. 
The scores represent the percentage of items on each study design-specific checklist endorsed, and 
7 
 
higher percentages reflect higher quality. Scores ranged from 60% to 100%, and of the 52 studies, 13 
scored 100%, seven scored 90-100%, 14 scored 80-90%, 12 scored 70-80%, and six scored 60-70%. 
Studies scoring lower tended to have qualitative designs. The most frequent quality issues included a 
failure to specify the underpinning philosophy of the research approach, so the congruence between 
the philosophical perspective and the research methodology was unknown, and a lack of reflexivity 
to locate the researcher culturally and theoretically, acknowledging the impact of the researcher on 
the research and vice versa. Studies scoring higher tended to utilise survey designs, consensus 
methods, and observations.  
 
Study design types 
This review included one case report, 20 cross-sectional studies yielding quantitative data, five 
studies that were opinion pieces, commentaries, or utilised consensus methodologies with experts, 
24 qualitative studies, two quasi-experimental studies, and one randomised controlled trial.  
 
Participant characteristics 
Participants were HCPs, people with dementia, carers, and people who had attended memory 
assessment services but not received a diagnosis of dementia at the time of participation. Sixteen 
studies included only the perspectives of HCPs, four studies included only the perspectives of people 
with dementia, one study included the perspectives of people without a diagnosis of dementia, and 
seven studies included only the perspectives of carers. Sample sizes ranged from two to 1409. The 
term ‘carer’ was used in most studies to refer to the individual accompanying the person receiving 
the diagnosis to the disclosure meeting. Other terms including ‘relative’ and ‘companion’ were also 





Studies were conducted in clinic and community settings, in the UK (Eccles et al., 2009, Bennett et 
al., 2018, Hillman, 2017, Innes et al., 2012, Manthorpe et al., 2013, Milby et al., 2017, Page et al., 
2015, Peel, 2015, Samsi et al., 2014, Stokes et al., 2014, Vince et al., 2017, Lecouturier et al., 2008, 
Bailey et al., 2019, McCabe et al., 2019, Xanthopoulou et al., 2019), USA (Burns et al., 2017, Lim et 
al., 2016, Lingler et al., 2016, Connell et al., 2009, Carpenter et al., 2008, Campbell et al., 2008, 
Bradford et al., 2011, Grill et al., 2017, Grossberg et al., 2010, Sakai and Carpenter, 2011, Wynn and 
Carpenter, 2017, Zaleta and Carpenter, 2010, Zaleta et al., 2012, Champlin, 2020), China (Zou et al., 
2017), The Netherlands (van Wijngaarden et al., 2018), Brazil (Shimizu et al., 2008, Raicher et al., 
2008), Belgium (Segers, 2009, Mormont et al., 2012), Australia (Phillips et al., 2012, Mastwyk et al., 
2014, Hansen et al., 2008), Denmark (Nielsen et al., 2018), Ireland (Moore and Cahill, 2013, Foley et 
al., 2017), Canada (Lee and Weston, 2011), Finland (Laakkonen et al., 2008), Israel (Karnieli-Miller et 
al., 2012), Germany (Kaduszkiewicz et al., 2008), Switzerland (Giezendanner et al., 2018), Japan (Abe 
et al., 2019), and Malta (Caruana-Pulpan and Scerri, 2014). Three studies used a pan-European 
design, involving several countries contributing to data collection (Porteri et al., 2010, Visser et al., 
2012, Woods et al., 2019) and one study was international (Villars et al., 2010). The majority of 
studies were conducted in the UK (12 studies) and the USA (13 studies).  
 
Themes 
Content of the diagnosis disclosure 
In a survey of specialist physicians in Denmark, most respondents reported that they always or often 
provided information on aetiology, progression, and causes of symptoms, and they tailored the 
information provided depending on the degree of cognitive impairment, specific type of dementia, 
and level of emotional distress (Nielsen et al., 2018). People with dementia and carers in other 
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studies reported receiving only basic information, and felt they lacked information (Samsi et al., 
2014), or that nothing was explained (Innes et al., 2012). Messages conveyed should be positive and 
hopeful, whilst still being realistic (Vince et al., 2017, Phillips et al., 2012, Lee and Weston, 2011, 
Lecouturier et al., 2008, Grossberg et al., 2010). People with dementia and carers indicated that they 
wanted to know more about the future and prognosis (Lecouturier et al., 2008, Laakkonen et al., 
2008, Grossberg et al., 2010, Lee and Weston, 2011), sources of support, and local community 
health and social services (Foley et al., 2017, Innes et al., 2012). The diagnosis disclosure should 
include information regarding well-being, such as how people with dementia can continue with life 
as much as possible, maintain their sense of self, and accept their identity as a person with dementia 
(Vince et al., 2017). 
 
Carers in two studies reported being unsure what to ask in the disclosure meeting (Manthorpe et al., 
2013, Laakkonen et al., 2008), and felt that approaching diagnosis in stages might be preferable to 
enable people with dementia and carers to absorb and process the information (Laakkonen et al., 
2008, Lecouturier et al., 2008). However, in one study 55% of respondents reported preferring to 
receive the whole disclosure up-front (Mastwyk et al., 2014).  
 
The diagnostic process should be structured to ascertain the beliefs, expectations, and potential 
misconceptions that people with dementia or carers might have. This might include determining 
what people with dementia already know about dementia (Lee and Weston, 2011), identifying 
patient-centred informational needs (Bennett et al., 2018) and may take place in pre-diagnostic 





Eighteen studies explored the emotional impact of receiving a diagnosis of dementia. Studies 
reporting on the emotional impact of the diagnosis on people with dementia suggested they had 
experienced negative emotions (Zou et al., 2017, McCabe et al., 2019), including feelings of 
depression (Segers, 2009, Laakkonen et al., 2008), anxiety or nervousness (Segers, 2009, Mormont et 
al., 2012, Lim et al., 2016), shock (Samsi et al., 2014, Milby et al., 2017, Innes et al., 2012), loss (Samsi 
et al., 2014), grief (Samsi et al., 2014, Laakkonen et al., 2008), dejection (Samsi et al., 2014), sadness 
(Mormont et al., 2012), fear (Milby et al., 2017, Phillips et al., 2012), and shame (Kaduszkiewicz et 
al., 2008). One study reported that the diagnosis disclosure also brought satisfaction at receiving an 
explanation (Mormont et al., 2012). Three studies reported that some people with dementia were 
either indifferent upon receiving the diagnosis (Segers, 2009), had not experienced significant 
distress (Zaleta et al., 2012), or showed initial anxiety that was not sustained over time (Burns et al., 
2017). A further study reported that anxiety decreased in people with dementia after receiving their 
diagnosis, particularly for those with high anxiety prior to the diagnosis (Carpenter et al., 2008). 
Studies on the perspectives of HCPs suggested that some people with dementia deny or minimise 
the diagnosis (Segers, 2009, Kaduszkiewicz et al., 2008). Studies exploring the perspectives of carers 
or family members found they reported feeling anxious (Segers, 2009, Laakkonen et al., 2008), 
uncertain (van Wijngaarden et al., 2018, Laakkonen et al., 2008), hopeless (Laakkonen et al., 2008), 
lonely (Laakkonen et al., 2008), that their hope and trust in the future was taken away (van 
Wijngaarden et al., 2018) and anxiety and uncertainty due to not knowing where to get help or what 
to do next (Laakkonen et al., 2008). One study found that carers reported a sense of relief and 
validation that their observations about something being wrong were correct, which in turn led to a 
sense of acceptance. However, this study also found that carers felt sad, terrified, overwhelmed, and 
worried (Champlin, 2020). HCPs reported feeling a need to manage their own emotional journey 
(Bennett et al., 2018). GPs reported a sense of trepidation regarding the disclosure (Phillips et al., 
2012), and were hesitant and expressed worry regarding the negative psychological impact upon 




Communication of the diagnosis 
Communication was explored in 21 studies. There were conflicting findings regarding using explicit 
terms such as ‘dementia’ or specific labels like ‘Alzheimer’s disease’ when communicating the 
diagnosis to people with dementia and carers. Five studies reported that such terminology should be 
used (Bennett et al., 2018, Grossberg et al., 2010) and was commonly used (Raicher et al., 2008, 
Nielsen et al., 2018, Bailey et al., 2019), but eight reported that HCPs tended not to use these terms 
(Zou et al., 2017, Zaleta et al., 2012, Segers, 2009, Phillips et al., 2012, Moore and Cahill, 2013, Milby 
et al., 2017, Kaduszkiewicz et al., 2008, Hansen et al., 2008). Reasons for not using specific 
terminology were that ambiguous language may be preferable when HCPs themselves are uncertain 
of the diagnosis (Zaleta et al., 2012, Milby et al., 2017), and unambiguous terms were not always 
helpful in facilitating the person with dementia’s understanding (Peel, 2015). Other reasons included 
minimising distress (Milby et al., 2017, Bailey et al., 2019), avoiding negative connotations of the 
word ‘dementia’ (Phillips et al., 2012), and avoiding pathologising the condition (Abe et al., 2019). 
Cultural differences were highlighted, suggesting that colloquial terms were used because they were 
more familiar to the local community (Abe et al., 2019).  
 
Considering communication patterns in consultations, one study found that HCPs tended to 
dominate the disclosure meeting by talking on average for 83% of the time. Emphasis shifted from 
the person with dementia to the carer even when the person with dementia was in the mild stages 
of the condition and still able to speak and contribute information (Wynn and Carpenter, 2017). 
Whilst patient-centred communication was noted in one study, findings suggested that aspects of 
communication such as emotional rapport-building were infrequent (Zaleta and Carpenter, 2010). 
Three studies indicated that written information should accompany disclosure meetings (Nielsen et 





There were mixed findings regarding who should disclose the diagnosis. One study suggested 
specialists should always take this role (Villars et al., 2010) with another suggesting that specialists 
could occupy a position of blame in contrast to the GP, who could provide support to patients 
(Phillips et al., 2012). However, this study also reported that GPs should take on the role of 
disclosure when a well-developed patient-doctor relationship existed because they would be known 
to the patient compared to a specialist. A Swiss survey reported that 75% of GPs disclosed the 
diagnosis themselves (Giezendanner et al., 2018). Other professionals have roles in disclosure, 
suggesting that discussing well-being should be undertaken by a multidisciplinary team (Vince et al., 
2017), although psychiatrists wanted more time to discuss well-being during the disclosure to avoid 
being seen as someone who only diagnoses conditions and prescribes medication (Vince et al., 
2017). 
 
The majority of articles agreed it was beneficial for carers to accompany the person with dementia 
to disclosure meetings (Phillips et al., 2012, Page et al., 2015, Nielsen et al., 2018, Grossberg et al., 
2010, Bradford et al., 2011, Lingler et al., 2016, Abe et al., 2019, Bailey et al., 2019, Giezendanner et 
al., 2018). Family members often wanted more information, and could receive education to help 
them cope in the future (Phillips et al., 2012, Bailey et al., 2019). Carers represent a reassuring 
presence for the HCP (Page et al., 2015), can help them communicate the diagnosis more effectively 
to the person with dementia (Grossberg et al., 2010), and help to recall details of the diagnosis 
(Bradford et al., 2011, Bailey et al., 2019). One study found that, within its sample, people with MCI 
showed a lack of health literacy, suggesting carers were necessary to help process and understand 
the information provided (Lingler et al., 2016). Further, one study suggested that carers are usually 
most troubled by symptoms of dementia, and using disclosure meetings to reassure them is 
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important (Abe et al., 2019). HCPs in one study suggested that fuller details of the diagnosis were 
disclosed to carers rather than people with dementia (Kaduszkiewicz et al., 2008). A key point here is 
the lack of people with dementia as participants in the included studies, which limits the ability to 
draw conclusions regarding their preferences for their own and others’ involvement.  
 
Attitudes towards diagnosis disclosure 
Studies investigating HCPs’ attitudes towards disclosing the diagnosis found it can be perceived as 
draining (Milby et al., 2017); they might feel like the ‘grim reaper’ when delivering bad news 
(Bennett et al., 2018), or worry that the process could ruin doctor-patient relationships 
(Kaduszkiewicz et al., 2008). Some psychiatrists may hold a medically rooted nihilistic and 
reductionist attitude due to a sense of hopelessness around potential interventions for people with 
dementia and a lack of appropriate services to support well-being (Vince et al., 2017). Geriatricians 
who did not provide information on progression and prognosis of Alzheimer’s disease to the person 
with dementia reported this was because the person with dementia did not ask, or the HCP was 
either fearful of a depressive reaction or felt the knowledge was of no use (Segers, 2009).  
 
Carers typically approached diagnosis disclosure as a useful event (Mormont et al., 2012), and felt 
that people with dementia had a right to know in order to begin treatment, face the condition 
positively, know what is happening to them, and plan for the future (Zou et al., 2017). Carers were 
divided on whether the diagnosis should be revealed in an up-front approach, or in stages (Mastwyk 
et al., 2014). Those who preferred an up-front approach felt it necessary for planning, and managing 
issues such as driving cessation. Carers felt empowered when HCPs explained how and where to get 
treatment (Mastwyk et al., 2014) and tended to prefer the HCP openly informing the person with 
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dementia of the diagnosis (Laakkonen et al., 2008). A good quality disclosure was associated with 
better carer adjustment in relation to sadness, depression, and acceptance (Woods et al., 2018). 
 
Only two studies considered attitudes towards diagnosis disclosure from the perspective of people 
with dementia themselves, with one finding that people with dementia tended not to agree with or 
acknowledge the information disclosed by the HCP (Peel, 2015). The other study found that people 
with dementia would prefer to receive a direct disclosure even though it might be a shock (Mastwyk 
et al., 2014).  
 
Use of diagnostic tests and assessments 
Four studies suggest that, prior to the disclosure meeting, HCPs should discuss what people with 
dementia and carers can expect from assessments, especially from brain scans and biomarker 
testing, and potential limitations or implications of diagnostic tests (Visser et al., 2012, Porteri et al., 
2010, Grill et al., 2017, Lingler et al., 2016). People with dementia and carers should have the choice 
to receive the results from assessments or not, and should have the opportunity to change their 
mind at any point (Porteri et al., 2010).  
 
Three studies suggested that brain scans should be reviewed in disclosure meetings (Nielsen et al., 
2018, Lingler et al., 2016, Grill et al., 2017) so people with dementia and carers can see the images. 
Two studies offered caution regarding how results of amyloid scans were communicated, where 
explanations should state that presence of amyloid indicates a risk for developing dementia whilst 
absence of amyloid does not indicate absence of illness (Grill et al., 2017), and that biomarkers are 
not yet a diagnostic tool in themselves (Burns et al., 2017). One study advocated for provision of 




Truth telling and deception  
Three studies considered the aspect of truth telling or withholding the truth of the diagnosis from 
people with dementia. One study reported that HCPs felt a truthful diagnosis was not necessary due 
to a lack of effective treatments and potential impact on pre-existing symptoms of anxiety or 
depression (Porteri et al., 2010). Conversely, a different study found that providing a truthful 
diagnosis did not create a negative emotional impact for people with dementia or carers, and 
instead helped to relieve anxiety or depression for both (Carpenter et al., 2008). The third study 
reported difficulties in delivering the diagnosis as people with dementia may try to normalise their 
experience, and HCPs must balance this with not deceiving the person with dementia as to the 
diagnosis (Peel, 2015).  
 
Timeliness 
Three studies considered the timing of receiving a diagnosis of dementia, with one study reporting 
that nearly half of carers surveyed across five European countries felt diagnosis was delayed (Woods 
et al., 2018). Reasons for delay included people with dementia refusing to be assessed, negative 
professional attitudes, and being told there was no point in a diagnosis. Receiving timely diagnoses 
could assist people with dementia in remembering their diagnosis (Bradford et al., 2011), but 
another study indicated potential detriment to well-being if provided before a person had processed 
what is happening and accepted the changes they are experiencing (Vince et al., 2017). 
 
Training and skills 
As far as can be determined from the included studies, there is no specific training available in how 
to disclose a diagnosis of dementia. In two studies HCPs reported receiving training in breaking bad 
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news, attending conferences on the topic, or using general guidelines for diagnostic disclosure 
(Vince et al., 2017, Nielsen et al., 2018). Despite disclosure often being performed by specialists, two 
studies indicated that primary care physicians should have training on disclosing sensitively (Foley et 
al., 2017) and integrating disclosure into their consultations (Villars et al., 2010). 
 
Discussion 
This review provides the only up-up-to-date comprehensive account, based on a rigorous systematic 
literature search, of common practice around the world in disclosing a diagnosis of dementia from 
the perspectives of people with dementia, carers, and HCPs. These findings suggest that telling the 
person with dementia the diagnosis is now common practice. However, HCPs may experience 
discomfort in revealing the diagnosis and consequently use euphemisms to describe the syndrome 
rather than explicit terminology. Generally, if diagnosis disclosure is provided as a one-off event, and 
without discussion of hopeful aspects or emotional rapport building, it has a negative impact on 
people with dementia and carers. Carers report needing to know more about the future and 
prognosis, and their preference is for the diagnosis to be disclosed in a realistic yet hopeful way. 
HCPs would benefit from guidance and support in how to disclose the diagnosis, and the disclosure 
should be approached as a process involving a multidisciplinary team rather than as a singular event. 
The findings suggest progress in normalising the diagnosis and reducing stigma but highlight that 
there is still more to be done.  
 
Disclosure was viewed as a negative process by HCPs who reported an attitude of hopelessness, and 
uncertainty around the exact diagnosis, prognosis, and how much people receiving the diagnosis 
already knows or can understand. HCPs highlighted that the information needed by people with 
dementia and carers is difficult to deliver due to the delicate balance between honesty and hope 
17 
 
(Bailey et al., 2016). HCPs do not appear comfortable with their position as someone who delivers 
bad news and can only provide limited treatment options. This review also identified that little 
consideration was given to patient-centred communication and expectations extending to cultural 
differences.  
 
Our findings suggest that disclosures can cause people with dementia to suffer emotionally (Zou et 
al., 2017). Similarly, emotional rapport-building is identified as important yet may not be frequently 
used in disclosures (Zaleta and Carpenter, 2010), suggesting that HCPs are not prioritising the 
emotional impact of receiving a diagnosis as a key consequence of the meeting. Whilst disclosure 
tended to have a negative impact for people with dementia and their carers, carers did report that 
disclosure was a useful event that enabled them to organise treatment and support, and discussion 
of aetiology, progression, and causes was helpful. However, carers expressed a need to know more 
about the future and prognosis following diagnosis. This finding shows consistency with a previous 
review (Werner et al., 2013), but the present review shows a step forward in the dialogue around 
truth-telling, in that simply knowing the diagnosis itself is not enough. Carers need to know what will 
happen to the person with dementia in the future, beyond the diagnosis, and what ramifications this 
will have for themselves as carers.  
 
Consistent with earlier reviews (Lecouturier et al., 2008, Werner et al., 2013) is the preference for a 
process approach to disclosure. This is supported by guidance from the UK Alzheimer’s Society 
(Alzheimer's Society, 2018) and the British Psychological Society (Watts et al., 2018) which suggest 
that delivering information in one session is overwhelming and instead disclosure should be 
embedded within the care pathway. People with dementia and carers need more time and space to 
process information provided in the disclosure, which could be achieved using follow-up 
appointments. Using follow-up appointments could aid with retaining information, as in the general 
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population 34-88% of what is said in medical appointments is forgotten, depending on the type of 
information provided, where general recall is higher for a discussion, but lower for specific 
information such as regarding lifestyle interventions (Richard et al., 2017). This is important, given 
the range of topics covered in a diagnosis disclosure, and it is likely that this figure is higher for 
people experiencing cognitive changes. More opportunities to impart the same information, or 
presenting smaller amounts of information more than once, could help people remember the 
diagnosis and its implications, whilst providing space to explore the emotional impact of the 
diagnosis. However, it must be noted that increasing the number of appointments would require 
greater resources, without which an increase in waiting times is likely and this is not desirable either. 
Involving other agencies, such as third sector agencies, could be useful.  
 
Strengths and limitations 
This review used a comprehensive search strategy across several databases to identify as many 
relevant articles as possible, although some articles indexed in other databases may have been 
missed. The rigor of the systematic search and quality review can be seen in that searching was 
completed by two reviewers, allowing for discussion and justification for inclusion or exclusion of 
each article, and a sample of articles were assessed for quality by a third, independent reviewer 
which resulted in a high level of agreement. Quality assessment was not used in previous reviews of 
this topic area (Werner et al., 2013), and showing how this review has moved the discussion 
forwards by highlighting methodological issues that must be considered in future work. Despite 
studies being of a variety of designs and conducted in different settings, the findings are generally 
consistent, suggesting that this review has identified realistic trends. The perspectives of people with 
dementia, carers, and HCPs were captured in this review, ensuring that findings are relevant to the 





Only studies written in English were included, and therefore some findings may have been missed. 
However, studies from across the world were included and despite some contradictory findings, 
generally there was agreement, suggesting that studies in languages other than English may not 
have significantly changed the results if included. Studies of all designs were included and, although 
this renders it impossible to synthesise numerical findings into meaningful quantitative analyses, the 
integration of qualitative and quantitative findings should be considered a strength. One 
methodological consideration to acknowledge is that much of the research included in this review is 
reliant on self-report techniques, either through use of surveys or qualitative interviews. Whilst 
surveys can reach a broad audience, and interviews can elicit rich details about the experience of 
disclosure, both methods of data collection can be affected by bias, and it is challenging to reliably 
compare or contrast practices reported by HCPs with the impact they have on recipients (Plejert et 
al., 2017). Only eight of the 52 included studies used observational methods (Hillman, 2017, McCabe 
et al., 2019, Peel, 2015, Sakai and Carpenter, 2011, Wynn and Carpenter, 2017, Xanthopoulou et al., 




Recommendations for clinical practice 
Communication skills do not reliably improve with experience alone (Cantwell and Ramirez, 1997) 
and consequently further training, supervision, and regular reflection on practice may support HCPs 
in navigating uncertainties and managing their own emotional journey. For HCPs in specialist roles, 
training should be specific to disclosing a diagnosis of dementia rather than generally about breaking 
bad news, and supervision should cover managing the emotions of the person with dementia and 
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the carer, as well as their own emotional responses. Communication skills training is mandatory in 
the majority of training programmes for all HCPs (Moore et al., 2018), but training to develops skills 
in shared communication, to raise awareness of supporting people with dementia and carers to 
assert themselves and maintain their agency and power during the disclosure, is needed. HCPs may 
benefit from guidance in understanding and supporting cultural differences and sensitivities in 
diagnosis disclosure. However, it is recognised that training is resource-intensive and relies upon 
having appropriately trained individuals who are available to train and support others. This is likely 
to be difficult across disciplines and in time-pressured healthcare environments. 
 
Pre-diagnostic counselling prior to disclosure could explore beliefs and expectations, and potentially 
mitigate negative impacts by ensuring people with dementia and carers are prepared. This may 
support people with dementia and carers to consider questions they could ask between meetings 
and provide greater opportunity to speak during disclosure meetings. Follow-up meetings could 
enable tailoring of information, an opportunity to re-confirm the diagnosis, and discussions of 
prognosis, future considerations, and access to local support. Involving multi-disciplinary teams 
could help to provide an holistic and hopeful disclosure, reducing the negative emotional burden on 
individual HCPs whilst also reducing the likelihood that the disclosure is viewed as a singular 
negative event by people with dementia and carers (Vince et al., 2017). Reassurance and a realistic 
sense of hope about the future should be emphasised throughout, and HCPs could discuss how 
people with dementia and their carers can maintain quality of life after diagnosis.  
 
Recommendations for people with dementia and carers 
Information about memory assessments and what typically happens could be provided through 
channels including posters or leaflets in GP surgeries and community spaces. Information about 
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what to expect when receiving the results of assessments may be provided ahead of disclosure 
meetings, although this could be distressing if information were given without having someone 
available to provide support or further explanations. People with dementia should be supported to 
ensure they can have someone attend the disclosure meeting with them if they wish. Encouraging 
people with dementia to arrange a follow-up appointment with their GP could be beneficial for 
asking further questions and considering the future implications.  
 
Recommendations for research 
Much of the research included in this review relies on recalling the disclosure experience, and there 
is disparity between viewpoints of people with dementia, carers, and HCPs. A sensible next step is to 
conduct research that directly observes disclosure meetings, considering all individuals involved. 
Whilst work in this area has already been undertaken involving people with dementia, carers, and 
HCPs (Peel, 2015), further work currently underway focuses on doctors only (Bailey et al., 2019, 
Xanthopoulou et al., 2019). More research that considers the three-way dialogue between people 
with dementia, carers, and HCPs, analysing what each brings to the disclosure and what each takes 
away, is needed. Most research to date is from the perspective of carers, with some from the 
perspective of HCPs. More research considering perspectives of people with dementia on diagnosis 
disclosure is needed to fully understand their wants and needs. Research combining all three 
perspectives is required to develop a realistic understanding of how disclosures can be best 
conducted to benefit everyone involved, more closely reflecting real practice.  
 
Researchers must respect the agency and rights of people with dementia to participate in research. 
Earlier reviews (Werner et al., 2013, Lecouturier et al., 2008) have not explored power dynamics 
between individuals involved in disclosures, or the agency that people with dementia possess in the 
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interaction. Only two studies in this review specifically considered attitudes towards diagnosis 
disclosure from the perspective of the person with dementia, although other studies have explored 
difference facets of the disclosure process. Less than half of the studies in this review recruited 
people with dementia, and of those that did, the number of participants with dementia was small. 
Developing an understanding of disclosure without involving people with dementia is inconsistent 
with patient-centred care. The lack of information regarding cultural differences in disclosure clearly 
shows that future research must explore this area to develop practices that support a culturally-
sensitive disclosure process.  
 
Future qualitative studies could demonstrate greater methodological quality by stating the 
underpinning philosophical perspective adopted by researchers during data collection and analysis, 
including reflexive statements to locate researchers culturally and theoretically. Increased 
awareness by journal editors and peer-reviewers regarding the reporting of qualitative methodology 
would encourage researchers to be transparent in their theoretical approaches.  
 
Conclusions 
Disclosing a diagnosis of dementia is a key process for people with dementia, carers, and HCPs. This 
review indicates that while changes in some aspects of disclosure have occurred over the last 
decade, disclosing a diagnosis of dementia remains a difficult and complex process, for which formal 
training and guidance is lacking. Receiving a diagnosis is generally a negative process for people with 
dementia, carers, and HCPs, and leaves carers in particular feeling uncertain over the prognosis and 
future of the person they care for. Pre-diagnostic counselling and follow-up appointments could 
enable realistic and hopeful discussions of the implications of receiving a diagnosis of dementia, 
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whilst reducing emotional burden on HCPs. This review highlights a need for more objective 
evidence that considers the perspectives of all individuals involved.   
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Figure 1: PRISMA flow diagram of included studies 
 
 














Albe et al., 2019: 
Perspectives on disclosure 
of the dementia diagnosis 
among primary care 
physicians in Japan: a 
qualitatively driven mixed 
methods study 




and a ranking task 
To investigate how 
primary care physicians 
in Japan approach 
disclosure of a dementia 
diagnosis to patients and 
family members 
Diagnoses were disclosed jointly to the person with dementia and 
their family members for all participants, and cooperation and 
well-being of family members was important to physicians in 
maintaining quality of life for the person with dementia. 
Physicians were concerned about the potential negative 
psychological impact on patients, the degree to which patients 
understood the information provided, and the stigma associated 
with dementia.  
Almost half of the sample reported they did not receive training 
in disclosing a diagnosis of dementia and were unsure if their 
approach was appropriate.   
70% 
Bailey et al., 2018: ‘How 
do they want to know?’ 
Doctors’ perspectives on 
making and 
communicating a 
diagnosis of dementia 




UK Qualitative focus 
groups 
To investigate the views 
and experiences of 
doctors making and 
delivering diagnoses in 
memory clinics 
Organisation of some memory clinics involves allied health 
professionals conducting assessments, so doctors disclosing the 
diagnosis can be meeting that patient for the first time, which 
feels unnatural and makes it difficult for the doctor to gauge the 
patients’ readiness and expectations. The diagnosis was seen as a 
useful framework to involve other services and open discussions 
about possible therapies. Participants reported managing the 
different audiences (patient and companion) in the consultation 
was challenging and balancing the needs of both could lead to 
conflict. Few participants reported receiving specific training and 
most relied on basic principles taught in medical school, and 
there was a lack of supervision and support in discussing the 
emotional impact on doctors themselves. Participants tended to 
use the word dementia, but some approached it gradually by 
introducing the idea of memory problems first. There was a 
tension between presenting a hopeful picture, whilst also being 
honest, and reflecting that there is uncertainty in the diagnosis. 
Participants reflected that due to service pressures there just 
wasn’t enough time to cover everything they wanted to in a 
disclosure meeting and consequently follow-up appointments are 
crucial.  
70% 
Bennett, et al., 2018: 
Developing a tool to 
support diagnostic 
delivery of dementia 





13 took part in 
focus groups, 
2 PwD, 4 
companions 
7 clinicians 
MAS clinics in 
a large UK city 
Qualitative 
interviews with 
thematic analysis to 
produce a tool for 
clinicians evaluated 
in focus groups 
To develop a tool specific 
to dementia diagnostic 
delivery based on 
clinician, patient and 
companion experiences 
Themes: 
1. Overcoming barriers to good delivery, 2. Navigation of multiple 
journeys (attendee’s emotions, clinician’s emotions) 3. Overt 
tasks (develop a supporting relationship, promote consent and 
choice, develop understanding, be patient centred, provide 
emotional support) 4. Covert tasks (Overcoming power imbalance 
between clinician and patient, continual adaptation, awareness 
and management of dynamics) 
75% 
 Focus groups: patients would like information about the 
appointment beforehand. Some experienced clinicians may not 
want a good practice guide 
Bradford et al., 2011: 
Knowledge of 
documented dementia 
diagnosis and treatment 
in veterans and their 
caregivers 
132 dementia 
patients and 183 
caregivers (122 





medical records with 
self-reported 
questionnaire 
To determine the extent 
to which patients’ and 
caregivers’ perceptions 




information in patients’ 
medical 
records. And to compare 
patients’ and 
caregivers’ perceptions 
to one another to 
explore the extent 
to which knowledge of 
dementia diagnosis and 
treatment is 
shared within the dyad. 
67% of carers and 24% of patients were aware of their diagnosis 
of dementia of some kind. For patients this may be because of 
lack of ability to recall. Unclear whether findings are attributable 
to participant’s factual knowledge or variation in disclosure 
practices. Patients more likely to recall that they had been 
prescribed a memory enhancing drug. Only in 10% of dyads did 
both caregiver and patient agree on the dementia diagnosis 
indicating that interventions should be dyadic. 
80% 
Burns et al., 2017: Safety 
of disclosing amyloid 
status in cognitively 











Part of a larger trial 
evaluating the effects 
of exercise on AD 
biomarkers. Mood 
was assessed using 
validated measures 
before the scan, at 
the disclosure visit, 6 
weeks and 6 months 
after disclosure 
To evaluate safety and 
tolerability of disclosure 
of elevated amyloid 
levels shown on PET 
scans 
There were no differences between the amyloid elevated group 
and the amyloid not-elevated group for depression at any time 
point.  
Anxiety increased in amyloid elevated participants at a low level 
on the day of disclosure but was not sustained at 6 weeks or 6 
months.  
Higher levels of anxiety and depression at baseline were modestly 
predictive of levels of anxiety and depression at follow-up.  
Amyloid elevated participants did not regret learning the 
outcome of their scan.  
The authors note that discussion of the scan frames the results 
conceptually as a risk factor for development of AD rather than as 
a diagnostic tool.  
Further, the authors stress using terms ‘elevated’ rather than 
positive to avoid confusion of positive being beneficial.  
90% 
Campbell et al., 2008: 
Dementia, diagnostic 
disclosure, and self‐
reported health status 




referral sites  
USA 
Secondary data 
analysis of survey 
To investigate the 
general awareness of 
cognitive impairment in 
persons with 
documented dementia,  
evaluate the subject’s 
recall of a diagnostic 
disclosure from a 
physician and their 
recollection of the 
discussion, and 
Thirty nine (26.2%) subjects reported being told by a physician 
about a diagnosis of dementia or memory problems. This recall 
was associated with younger age (Po.001), male sex (P5.04), and 
higher education level (P5.02). African Americans reported poorer 
self-rated health scores (odds ratio (OR) 52.4, 95% confidence 
interval (CI) 51.1–5.1).  
Persons who reported being told by a physician of a diagnosis of 
dementia were more likely to report poorer self-rated health 
(OR52.5, 95% CI 1.1–5.5). 
90% 
determine whether this 
awareness of cognitive 
impairment or the recall 
of diagnostic disclosure is 
associated with poorer 
self-rated health scores. 
Carpenter et al., 2008: 
Reaction to a dementia 
diagnosis in individuals 
with Alzheimer's disease 













Before and after 
diagnosis 
questionnaire 
To examine the 
psychological reaction to 
receiving a dementia 
diagnosis in individuals 
attending an Alzheimer’s 
Disease Research Centre  
(ADRC) 
Most individuals and their companions seeking a dementia 
evaluation do not experience adverse psychological reactions 
when they receive diagnostic feedback.  Symptoms of anxiety and 
depression remain stable or even decline immediately after 
diagnosis.  Severity of dementia, age, sex, and education appear 
to have no significant effect on this outcome. 
Little change was seen in depressive symptoms. In contrast, 
symptoms of anxiety seem to decrease after diagnostic feedback. 
In particular, individuals who  started  the  evaluation  process  
with  high  levels  of anxiety were likely to experience significant 
relief after they received  diagnostic  information.   
80% 
 
Caruana-Pulpan & Scerri 
2014: Practices in 
diagnosis, disclosure and 
pharmacotherapeutic 
management of dementia 
by general practitioners –
a national survey.  
GPs in Malta 193 Survey, Malta National survey To explore, via a national 
survey, the practice 
patterns of GPs with 
respect to their ability to 
diagnose, disclose and 
pharmacotherapeutically 
manage dementia in 
their primary care setting 
A considerable number of GPs (62.2%) indicated that they do not 
routinely disclose the diagnosis, even though more than half of 
the respondents were in favour of the fact that disease disclosure 
may actually help the patient and the caregiver in future planning 
and treatment decisions. On disclosing, GPs are unsure of the 
suitable terminology to use in describing the condition to their 
patients and/or caregivers, with dementia being the most likely 
used term (33.7%) followed by memory problems (26.4%). Most 
physicians would prefer to disclose on being sure of a correct 
diagnosis and would do so to both the patient and the caregiver 
or relative. 
80% 
Champlin 2020: The 
informal caregiver’s lived 
experience of being 
present with a patient 
who receives a diagnosis 





face interviews with 
a phenomenological 
analysis approach 
To understand the 
informal caregiver’s 
experience of being 
present with a loved one 
when he or she receives 
a diagnosis of dementia, 
and what the 
constituents of the 
meaning that they assign 
are 
Caregivers are usually aware that there is something wrong with 
the person they care for and can experience feelings of relief and 
validation when the diagnosis is disclosed, which helps lead to a 
sense of acceptance. Alongside this were emotional responses 
that involved feeling sad, terrified, worried and overwhelmed, 
but coupled with a need to stay strong. Caregivers watched for an 
emotional response in the person with dementia when the 
diagnosis was disclosed, and reported seeing fear, sadness, and 
perhaps confusion, but sometimes no response. Caregivers 
reported wanting a road map to help them navigate the future 
and understand how they might care for the person with 
dementia. 
100% 
Connell et al., 2009: Black 
and white adult family 
members' attitudes 
toward a dementia 
diagnosis 
178 adults with 
varying exposure 
to AD (including 
first-degree 
relatives of people 









The primary purpose of 
the present study was to 
examine potential 
benefits of and barriers 
to diagnosis from the 
perspective of black and 
white adults directly 
Family members affected by AD endorsed a wide range of the 
benefits but few of the barriers to obtaining a diagnosis examined 
in this study. The most frequently endorsed benefits pertained to 
obtaining information, finding out what was wrong, and 
prompting future plans. In addition to the lack of a cure for AD, 
the beliefs that little can be done for someone with AD, that 
there is a lack of effective treatment, and that obtaining a 
100% 
primary caregivers 
of people with AD, 




nor an AD 
caregiving history 
affected by AD; a 
secondary purpose was 
to explore black–white 
differences in these 
perceptions. 
diagnosis was a demanding process for families were the barriers 
most frequently endorsed. 
 
Black respondents expressed more-positive views of obtaining a 
diagnosis than their white counterparts. Black respondents more 
likely to strongly endorse a number of benefits, but they were 
also less likely to view the fact that there is currently no cure or 
effective treatment as a barrier to diagnosis 
Eccles et al., 2009. 
Improving professional 
practice in the disclosure 
of a diagnosis of 
dementia: a modeling 




from 179 teams. 
All professionals 











controlled trial of the 
effect of one theory-
based and two 
pragmatic 
interventions on the 
intentions of a 
random sample of 
members of OAMHTs  
To evaluate a theory 
based intervention 
alongside two pragmatic 
interventions. A 
modelling experiment 
with the primary 
outcome of intention 
None of the interventions changed intentions or behavioural 
simulation scores in relation to finding out what the patient 
already knows/suspects about their diagnosis, using the actual 
words ‘dementia’ or ‘Alzheimer’s disease’ when talking to the 
patient or exploring what the diagnosis means to the patient. 
90% 
Foley et al., 2017: "We're 
certainly not in our 
comfort zone": a 
qualitative study of GPs' 
dementia-care 
educational needs 
14 GPs, 12 family 
carers, and 5 PwD 
Ireland Qualitative 
interviews 
To explore GP’s dementia 
care education needs to 
inform the development 
of a primary care 
dementia educational 
programme 
All participants expressed the importance of disclosure and the 
need for GPs to receive training on how to disclose sensitively.  
The need for GPs to provide information on sources of support 
and local community-based health and social care services was 
widely expressed.  
Some GPs recognised that their role included supporting people 
through the emotional impact of what can be a devastating 
diagnosis. However, GPs tended not to identify counselling as a 
training need, even though carers and PwD did.  
85% 
Giezendanner et al., 
(2018): Early diagnosis 
and management of 
dementia in general 
practice – how do Swiss 
GPs meet the challenge? 
882 GPs Switzerland  Survey To explore GPs’ approach 
to the diagnosis, 
disclosure and 
management of 
dementia, and their 
perception of the 
provision of care and 
health services for 
individuals with 
dementia via a national 
survey. 
Three quarters of respondents disclosed the diagnosis 
themselves, with only 9% reporting that they almost never or 
never took on this role. Almost 90% reported that disclosures 
involved the person with dementia and their family members. 
Disclosures lasted an average of 28.5 minutes.  
100% 
Grill et al., 2017:  
Communicating mild 
cognitive impairment 
diagnoses with and 
without amyloid imaging 
19 experts US Workgroup meeting  To identify 
recommendations and 
best practices for 
delivering a diagnosis of 
MCI 
Patients should be provided with a written summary of the 
diagnosis and treatment recommendations, services available, 
and local resources.  
Careful, honest and compassionate dialogue should be used to 
help patients validate and understand their condition.  
Patients should have the opportunity to discuss whether they 
would like further testing, e.g. amyloid imaging, and what the 
implications are for clinical management. The clinician should 
discuss what the patient and their family can expect from the 
85% 
scan, and the limitations of it. The results of amyloid scans should 
be delivered in person and described using terminology related to 
the presence or absence of amyloid and not the amount or any 
link to severity. Clinicians should explain that negative scans do 
not mean absence of illness, and that positive scans represent a 
risk for further decline. Clinicians may wish to review the images 
of the scans with patients.  
Grossberg et al., 2010:  
The art of sharing the 
diagnosis and 
management of 
Alzheimer's disease with 
patients and caregivers: 
Recommendations of an 
expert consensus panel 









primary care physicians 
in communicating the 
diagnosis and 
management of AD 
The diagnosis should be a process rather than an event, over 
several visits, to introduce the possibility of a diagnosis gradually.  
Family members should be present at disclosure and subsequent 
visits to help the physician to communicate the diagnosis 
effectively. 
Diagnoses should be disclosed in a private, comfortable, quiet 
location, with ample time for the visit. Distractions such as phone 
calls should be avoided.  
Specific language e.g. Alzheimer’s should be used unless cultural, 
educational, or other factors deem this inappropriate. Because of 
the negative connotations, physicians should try to emphasise 
hopeful aspects, such as functioning that is preserved and 
capabilities that the PwD has.  
Physicians should position themselves as a partner of and 
advocate for the PwD and their family, and a tailored approach 
should be taken. 
Physicians should discuss with carers what stage the PwD is at 
and the likely prognosis for the next six months, and what 
resources may be helpful. Basic literature should be provided. 
Discussions about driving should begin early in process.  
100% 





Factors impacting on early 
diagnosis 
25 GPs Australia Focus groups and 
semi-structured 
interviews 
To achieve a greater 
understanding of 
dementia diagnosis from 
the perspective of GPs 
GPs reported that rather than disclose the diagnosis using explicit 
terms, a discussion over a number of consultations is preferred, 
where the PwD can begin to realise for themselves that they have 
memory problems. GPs made judgements about whether the 
PwD would be comfortable with explicit terms and when it would 
be appropriate to talk to them about the issue.  
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Hillman 2016: Diagnosing 
dementia: Ethnography, 
interactional ethics and 
everyday moral reasoning 
51 consultations 
observed 
13 interviews with 
memory clinic 
staff 
UK Observations in 
memory clinics 
To explore the 
construction of morals 
whilst highlighting the 
social, collaborative, and 
processual nature of 
reaching a diagnosis 
Each person should be treated individually and there are no text 
book rules about how to disclose.  
Clinicians expressed a tension between recognising that the 
patient is an individual with the capacity to make free and 
reasoned choices, and that the diagnosis cannot be disentangled 
from the perceptions, needs and concerns of other people in the 
patient’s life who might need more information.  
Disciplinary and organisational cultures play a role in framing the 
consultation, where the impetus is on achieving the correct 
diagnosis in a reliable way, rather than on how it is delivered. 
Clinicians face a tension between wanting to use time as a 
resource to build up to delivering the diagnosis, but also feeling 
under pressure to not provide another appointment and instead 
90% 
to apply a diagnostic label, diagnose promptly and free up 
appointments for other people in the face of increasing 
caseloads.  
Visual evidence from CT scans can help clinicians frame the 
diagnosis in an objective way and show the transition from 
memory problems to a diagnosis, and move the conversation 
towards treatment and intervention plans.  
Innes et al., 2014: 
Dementia diagnosis and 
post-diagnostic support in 
Scottish rural 
communities: Experiences 
of people with dementia 
and their families 
18 participants (6 




To report service user 
views about diagnostic 
processes in a remote 
and rural region 
Most diagnoses were delivered face to face by a clinician. 
Participants wanted to receive an explanation and more 
information and support regarding available care. Participants 
reported that nothing was explained when they were diagnosed.  
Participants reported feeling the diagnosis came as a shock, 
despite an awareness of their memory problems prior to 
assessment.  
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Kaduszkiewicz et al., 
2008: Telling 'the truth' in 
dementia-Do attitude and 










GPs and 96 
specialists) 
Germany Qualitative 
interviews and a 
questionnaire 




between GPs and 
specialists with regards 
to diagnosis and 
disclosure of dementia 
GPs reported that patients deny their diagnosis when it is 
disclosed and try to convey that all is well.  
GPs worried about ruining the doctor patient relationship and 
avoid conflict with the patient.  
21 GPs reported using language other than dementia or 
Alzheimer’s and instead use terms like normal ageing process, or 
attribute it to circulatory issues.  
Both specialists and GPs tended to report more fuller details of 
the diagnosis to the relatives rather than the patient, and use 
explicit terms. Only one third of specialists and half of GPs used 
the terms Alzheimer’s and dementia with patients.  
A large proportion of GPs strongly (35%) or partially (40%) 
confirmed that patients felt ashamed when confronted with signs 
of cognitive impairment. Results from specialists were similar.  
50% of GPs and 30% of specialists were interested in further 
training concerning communication with PwD and relatives.  
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Karneili-Miller et al., 
2012: Expectations, 
experiences, and tensions 
in the memory clinic: the 
process of diagnosis 
disclosure of dementia 
within a triad 
10 patients and 17 
companions 
Two memory 




after the visit to the 
memory clinic 





first time encounters that 
deal with assessment 
and disclosure of the 
dementia diagnosis 
Many patients expressed disappointment or discontent following 
the consultations due to an absence of tangible solutions or due 
to the physician’s style of interaction and communication with 
the patient and companion. For example, patients felt 
disempowered when physicians spoke directly to the companion 
instead of them. There is a difference in perspective between 
patients who endorsed their memory difficulties and those who 
did not, with the latter experiencing more offense.  
Companions wanted an explicit explanation of what they can and 
should do, where they might receive support and guidance. 
However, companions expressed that they were not given 
solutions and guidance.  
Some companions felt a follow-up session to deepen their 
understanding was necessary. The lack of details provided in the 
session left companions feeling insecure about how to proceed.  
70% 
Some companions reported that the physician expressed 
impatience and even contempt towards the PwD, making rude 
interruptions.  
Some companions however expressed that they were glad 
someone was listening and was sympathetic to their feelings. 
Companions whose struggles and efforts were recognised and 
acknowledged felt reassured and empowered.  
Laakkonen et al., 2008: 
How do elderly spouse 
care givers of people with 
Alzheimer disease 
experience the disclosure 
of dementia diagnosis and 
subsequent care? 
1214 spousal 
carers of people 
with AD (1943 
sampled to 
participate) 
63 spousal carers 
participated in the 
qualitative part 
Finland Postal questionnaire 
and qualitative 
interviews 
To explore participants 
experiences regarding 
diagnosis disclosure and 
subsequent need for 
advance care planning 
97% of carers preferred that the physician openly informed the 
PwD of the dementia diagnosis. 55% of the carers felt their 
spouse had developed depressive symptoms after disclosure, and 
68% of carers felt that their awareness of the dementia had 
caused them grief or symptoms of depression.  
Carers in the qualitative study described feelings of hopelessness 
and loneliness, with particular examples occurring when they had 
not been invited for a follow-up appointment with the physician. 
Carers expressed feelings of uncertainty and anxiety, due to not 
knowing where to get help or what to do next. Carers felt 
disappointed with the lack of support and follow-up care, and felt 
uncertain about the prognosis.  
Some carers felt guilty about not asking enough questions, and 
some reported not knowing the right questions to ask. Carers 
expressed a desire for a further appointment once they had 
absorbed the information and understood it better.  
80% 
Lecouturier et al., 2008: 
Appropriate disclosure of 
a diagnosis of dementia: 
identifying the key 
behaviours of 'best 
practice' 
4 PwD 
6 informal carers 
8 panellists (health 
and social care 
professionals) 
UK Mixed methods 
approach involving a 
literature review, 
semi-structured 
interviews, and a 
consensus panel 
process involving a 
questionnaire and a 
meeting 
To identify key 
components of the 
process of disclosure and 
to identify the range of 
disclosure behaviours 
using three different 
methods 
The literature review revealed a total of 199 components of 
appropriate disclosure.  
The interviews identified 112 behaviours. 
The questionnaire completed by the panellists identified 55 
behaviours.  
Of the total 220 behaviours identified, 109 overlapped.  
Behaviours could be grouped into 8 categories: 1. Preparing for 
disclosure, 2. Integrating family members, 3. Exploring the 
patient’s perspective, 4. Disclosing the diagnosis, 5. Responding 
to patient’s reactions, 6. Focusing on QoL and well-being, 7. 
Planning for the future, 8. Communicating effectively.  
70% 
Lee & Weston, 2011: 
Disclosing a diagnosis of 
dementia: Helping 
learners to break bad 
news 
 Canada Opinion piece To provide advice and 
strategies for disclosure 
of a dementia diagnosis, 
especially for those 
teaching others how to 
do it 
Suggestions for disclosure include: determining what the patient 
already knows about dementia and addressing misconceptions 
that may have arisen from experiences. Dementia might be 
described as part of a continuum of memory loss, with emphasis 
placed on preservation of function in the early stages.  
Provide realistic hope by highlighting individual variation in the 
manifestation and progression of dementia, and availability of 
treatment options. Healthcare professionals may discuss how to 
manage dementia and therapeutic options available.  
Healthcare professionals should emphasise non-abandonment 
and facilitate a caring committed relationship between PwD and 
the family physician. 
80% 
Lim et al., 2016: 
Disclosure of positron 
emission tomography 
amyloid imaging results: a 
preliminary study of 
safety and tolerability 
11 participants 
who were part of a 
larger study (n=63) 













wished to know their 
status were told and 






To evaluate the 
consequences of Amyloid 
Beta (AB) disclosure on 
mood, subjective sense 
of memory impairment, 
lifestyle, and perceived 
risks of AD.  
Participants who had a negative AB result were relieved but 
conscious it could change over time. Participants with a positive 
AB result were anxious but not surprised, and had shared this 
information with others and sought additional information on the 
internet.  
AB positive participants had made lifestyle changes, experienced 
no negative effects on their mood or subjective sense of memory 
impairment. 
A psychoeducational brochure provided helped participants to 
understand the link between environmental and genetic risk 
factors and the future progression to AD, and they found it useful 
and informative. The brochure did change perceptions of risk for 
participants (either AB positive or negative).  
100% 
Lingler et al., 2016: 
Development of a 
standardized approach to 
disclosing amyloid 
imaging research results 
in mild cognitive 
impairment 
10 dyads (carer 
and person with 
MCI) involved in a 
simulated 
disclosure and one 
to one interviews, 
and 8 of these (4 
with MCI and 4 
carers) 










of PET results (4 
positive, 4 negative, 
and 4 inconclusive) 
with one to one 
interviews to 
complete a survey, 
and then a focus 
group with 8 of the 
participants 
To test materials 
developed for use prior 
to amyloid imaging and 
when disclosing results 
of amyloid imaging in the 
context of MCI 
Surveys revealed that participants were satisfied with the 
disclosure process. All participants had also taken a health 
literacy test, and half of those with MCI showed a lack of health 
literacy, confirming the need to have disclosure sessions with a 
companion present.  
A theme from the focus group of best practice recommendations 
suggested the following ideas: offer pre-test counselling, use 
clear graphics, review patients’ brain image scans in the 
disclosure, offer take home materials describing follow-up 
options, call patients post-disclosure to answer emerging 
questions, and communicate seamlessly with primary care 
providers.  
A second theme was that knowledge is power, and despite the 
outcome of the tests participants generally felt that knowing 
enabled them to be strong and to make decisions about their 
futures.  
60% 
Manthorpe et al., 2013: 
From forgetfulness to 
dementia: clinical and 
commissioning 
implications of diagnostic 
experiences 
27 people with 
memory problems 
and 26 supporters 








understanding of the 
experiences of people 
developing dementia and 
of their carers, to inform 
practice and decision 
making 
Patients and carers felt that communication wasn’t necessarily a 
dialogue as although there was time for questions in the consult, 
many did not know what to ask or what information they might 
need.  
Some felt they received enough information, but others felt their 
concerns and questions were disregarded by physicians telling 
them they were okay.  
Support tended to be generic rather than person-centred and in 
response to their concerns.  
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Mastwyk et al., 2014: 
Disclosing a dementia 
diagnosis: what do 









interviews and use of 
feedback sheets to 
record what was 
discussed during the 
appointment  
Tto  identify helpful 
strategies for clinicians in 
meeting the wants and 
needs of this patient 
group and those of their 
families 
Several patients reported that the disclosure should be direct, 
even though it would be a shock, although some patients felt it 
depended on the individual and should be done sensitively. 
Carers’ views were very similar. 
Patients felt that the doctor should be sure of the diagnosis 
before it was disclosed. 
Attributes of doctors considered a requirement for this role were 
supportive, being a good listener, and being easy to understand.  
65% 
Carers felt that they did not receive enough information during 
the disclosure. 
55% of patients preferred to receive all information about the 
diagnosis, treatment, and prognosis all at once and up front, 
whereas 35% preferred to receive it in stages. 75% of patients felt 
that written information should accompany this. Carers were 
equally divided with 50% favouring an up front approach, and 
50% preferring to receive it in stages. Those favouring an up front 
approach felt it was necessary for planning, and to manage issues 
such as driving. 80% of carers felt written information would be 
helpful. 
Carers appreciated physicians who provided a sense of hope 
through explaining how/where to get further treatment and felt 
that this empowered them.  
McCabe et al., (2019): 
Patient and companion 
shared decision making 
and satisfaction with 
decisions about starting 
cholinesterase medication 









To examine how 
decisions are made 
about whether to start 
cholinesterase inhibitors 
at diagnosis disclosure 
meetings 
Patients and companions completed the Patient Experience 
Questionnaire about their disclosure meeting and 59.7% of 
patients and 35.9% of companions expressed uncertainty on the 
Outcome scale, 51.5% of patients and 26.8% of companions 
reported barriers to communication, 53% of patients and 21.7% 
of companions felt negative or no positive emotion. 4.6% of 
patients described communication as less than optimal. Overall, 
patient experience of the disclosure meeting was somewhat 
negative. 
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Milby et al., 2017: 
Diagnosis disclosure in 
dementia: Understanding 
the experiences of 
clinicians and patients 
who have recently given 








To explore the lived 
experience of individuals 
who have recently given 
or recently received a 
diagnosis of dementia 
Reactions to receiving a diagnosis described by both patients and 
clinicians involved shock, fear, and acceptance, but the most 
common reactions are denial and avoidance. Patients use 
avoidance to manage their loss of sense of self and anxieties 
about the future, and clinicians use avoidance by not using 
explicit terms due to a lack of certainty about the diagnosis, and a 
desire to minimise distress, as well as respect for patients’ wishes 
not to know the diagnosis.  
Supportive staff at the MAS put patients at ease and help them to 
engage with the process. However, a diagnosis delivered without 
provision of information contributed towards anxiety.  
Clinicians reported that working with other members of health 
and social care helped to facilitate post-diagnostic support. 
Working with other staff also helps to increase confidence in the 
diagnosis.  
Clinicians reported that disclosure was draining and that patients’ 
distress does affect them. Being able to share this with a 
colleague helps to minimise the personal impact.  
Clinicians felt that a further appointment was needed after 
disclosure, with the same professional who had disclosed, but 
heavy caseloads meant that this was often not available.  
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Moore & Cahill, 2013: 
Diagnosis and disclosure 








To recognise obstacles to 
disclosure and explore 
the extent to which 
Only three participants claimed they would normally talk openly 
about dementia when disclosing the diagnosis;, instead six of the 
GPs tended to explicitly avoid using the word dementia.  
70% 
comparative study of Irish 
and Swedish General 
Practitioners 
dementia is considered a 
stigmatising illness for 
GPs in Ireland and 
Sweden 
Mormont et al., 2012: 
Experiences of the 
patients and their 
caregivers regarding the 
disclosure of the diagnosis 
of Alzheimer’s disease: A 
Belgian retrospective 
survey 





over one year 
Belgium Structured interview  To report the experience 
and 
agreement/disagreement 
of patients and 
caregivers regarding AD 
diagnosis disclosure 
29% of patients declared that they had suffered from the 
disclosure, but caregivers reported only 15% of patients were still 
suffering. 85% of caregivers felt the diagnosis had been useful.  
Patients who could remember their diagnosis significantly more 
frequently reported that they had suffered compared to those 
who could not recall, and that they were more anxious.  
Caregivers of patients who could remember their diagnosis 
reported significantly more frequently that the patient had 
suffered, and was still suffering from the disclosure, with a 
reaction of sadness, depression, anxiety, but also satisfaction to 
receive an explanation.  
The disclosure of AD was responsible for anxiety or sadness in 
approximately one third of patients.  
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Nielsen et al., 2018: 
The process of disclosing 
a diagnosis of dementia 
and mild cognitive 
impairment: A national 
survey of specialist 







Denmark Online questionnaire To investigate the 
process and content of 
diagnostic disclosure 
meetings in Danish 
dementia diagnostic 
services. 
98% reported that disclosure is almost always/often performed 
by a physician and 61% reported that a nurse almost 
always/often participated in these meetings. 
54% never/rarely disclosed on the first encounter. 56% had the 
opportunity to find out expectations before the meeting, but for 
31% this was never/rarely possible. 
98% of participants almost always/often discussed 
pharmacological treatments at the disclosure meeting, and 64% 
offered follow-up (although 28% never/rarely did so). 95% 
provided information on psychosocial support. 81% provided 
written materials to support the verbal information.  
Patients were encouraged to bring a family caregiver to the 
disclosure meeting and most participants disclosed to them 
jointly.  
78% of participants regularly used the term AD or dementia of 
the AD type (52%), or dementia (39%). No respondents used 
terms senility or age-related impairment.  
Most respondents shared results from brain scans/assessments 
and informed on aetiology, progression, causes of symptoms. 
However, few respondents gave information on prognosis and 
future symptoms, and the amount of information given was 
dependent on the degree of cognitive impairment, the specific 
type of dementia and the level of emotional distress.  
100% of respondents discussed issues such as handling 
medications and 87% discussed driving.  
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Page et al., 2015: 
‘Rydym Eisiau Gwybod’ 
the dementia diagnosis 
disclosure preferences of 
people in North Wales 







Clinical audit To quantify patients’ 
preferences for 
diagnostic disclosure 
84.1% of patients included in the audit preferred their diagnosis 
to be disclosed jointly to themselves and a relative or 2.7% to 
themselves and a third party (a carer). 8.3% of patients preferred 
to receive their diagnosis alone. All but one of the 4.7% of those 
60% 
who did not want to know wanted their diagnosis to be disclosed 
to a relative.  
Patients who expressed a preference for non-disclosure were 
5.74 times more likely to no have their preferences actioned than 
those requesting disclosure. 
Patients requesting joint disclosure were less likely to have their 
preferences ignored, suggesting the companion represents a 
reassuring presence not just for the PwD but also the healthcare 
professional.  
Peel, 2015: Diagnostic 
communication in the 











Video recording and 
conversation analysis 
of memory clinic 
appointments 
To understand why 
previous literature labels 
theo disclosure process 
as difficult, and to 
generate patient 
oriented advice on the 
process 
Patients tend not to agree or acknowledge the news delivered by 
the doctor, even when doctors take an affiliative conversation 
style by including the patient in the conversation.  
Bad news tends to be ‘shrouded’ with positives. 
Some interactions do not necessarily need the diagnostic labels to 
be explicit for the diagnosis to be communicated. Unambiguous 
naming of dementia/AD doesn’t always help the patient 
understand what is happening.  
Diagnosis is an ongoing, repetitive discussion between healthcare 
professionals, patients, and carers.  
Patients themselves tend to normalise their experience, and 
doctors interact with this, which presents the doctor with a 
situational dilemma of having a smooth consultation but also not 
deceiving patients and giving them the opportunity of a timely 
diagnosis.  
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Philips et al., 2012: 
Difficulties in disclosing 
the diagnosis of 
dementia: A qualitative 
study in general practice 
21 GPs Australia Qualitative 
interviews 
To explore GPs’ 
perceptions of barriers to 
disclosing the diagnosis 
of dementia 
Disclosure was felt to be difficult if GPs perceived patients to be 
hiding or denying symptoms of dementia. Disclosure is easier if 
the patient is already thinking about that diagnosis.  
GPs in this study reported feeling a sense of trepidation about 
disclosure as patients were often fearful of the diagnosis. GPs felt 
that if there was a well-developed doctor patient relationship 
they should be the one to disclose though, rather than a specialist 
who may not be known to the patient. However, some 
participants felt that the specialist could occupy a position of 
blame, and the GP was then in a position to support their 
patients. Some GPs felt that disclosure would impact the doctor 
patient relationship.  
Family members were felt to be helpful as they usually wanted to 
know more information, which the GP could focus on, especially 
if the patient discounted the implications of the diagnosis. 
Providing education to carers about the patient’s behaviour was 
felt to be important to help them cope with the consequences of 
the condition.  
GPs felt it was important to offer hope during the disclosure by 
confirming peoples’ fears and giving them a constructive way to 
move forwards.  
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Some GPs reported using terms such as memory impairment 
rather than dementia to avoid negative connotations of the word 
dementia.  
Porteri et al., 2010: 
Diagnosis disclosure of 
prodromal Alzheimer 
Disease – Ethical analysis 
of two cases 
Two patient cases Europe Description of two 
clinical cases 
To consider if and how 
diagnosis should be 
disclosed in two cases 
from an ethical 
perspective 
Patients should be given the choice whether to receive the results 
or not before the assessments take place, and patients should 
have the chance to change their mind at any point.  
The authors suggest that a due to the lack of effective 
treatments, a truthful diagnosis disclosure is not necessary to 
guarantee the best available treatment in prodromal AD.  
Disclosure and the terminology used should be based on the 
patient’s current socio-personal context, considering their mood 
and family support.  
Biomarkers should be treated with caution as the presence of 
biomarkers doesn’t necessarily translate into the same clinical 
situation in the future. 
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Raicher et al., 2008: 
Alzheimer’s disease 
diagnosis disclosure in 
Brazil: a survey of 
specialised physicians’ 
current practice and 
attitudes 
181 Physicians (of 
a possible sample 
of 970 potential 
respondents)  
Brazil Questionnaire To investigate practices 
and attitudes of 
specialised physicians 
concerning AD diagnosis 
disclosure in Brazil 
85.6% of respondents always used clear terminology such as 
dementia or AD, and the rest used terms such as memory 
impairment, forgetfulness, senility, or sclerosis.  
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Sakai & Carpenter 2011: 
Linguistic features of 


















To explore the 





Physicians dominated the conversations speaking on average for 
83% of the time. Patients spoke for 10% of the tome and 
companions spoke for 6% of the time. Companions spoke more 
when the patient had dementia than when they did not.  
Patients and companions underestimated the time the physicians 
spoke, and overestimated their total time talking.  
Physicians used fewer first person singular pronouns than 
patients and companions.  
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Samsi et al., 2014: 
Negotiating a labyrinth: 
experiences of 
assessment and 
diagnostic journey in 
cognitive impairment and 
dementia 





services in UK 
Interviews before 
and after diagnosis 
disclosure 
To understand the 
experiences, 
expectations and service 
needs of people with 
cognitive impairment 
and their carer along the 
service pathway from 
early awareness to 
diagnosis disclosure 
Many participants in this study felt supported by practitioners at 
the time and that details of their condition had been explained to 
them.  
Some participants described feeling shock, loss, grief, and 
dejection, and some of these felt that the process of imparting 
the diagnosis has increased these feelings.  
Participants wanted to know the long term prognosis, but felt 
that a staged process of diagnosis disclosure would have helped 
them to take the news on board, as they had little time to discuss 
concerns and questions.  
Carers were keen to talk to the PwD before speaking further to 
the practitioner because this interaction tended to generate 
further questions.  
Participants expressed that they had lacked information, had only 
been given basic information, and practitioners had disregarded 
their need to know more.  
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Not all types of dementia were supported, for example 
participants who received a diagnosis of vascular dementia in this 
study were discharged without support from secondary care 
because they were not eligible for medication, and reported 
feeling helpless, shocked, lost and confused.  
Participants who had been assessed and diagnosed in their own 
homes reported a positive experience, whereas some participants 
visiting clinics did not.  
Segers, 2009: 
What Belgian geriatricians 
tell their patients with 
Alzheimer's disease and 




response rate of 
an initial 309 
approached) 
Belgium Questionnaire using 




towards disclosure of AD, 
and whether these 
opinions differ from 
those of neurologists and 
neuropsychiatrists.  
Participants preferred to use the term memory disease (59% ) 
over AD (48%) with PwD, but preferred to use AD with relatives 
(87%). 
More than 55% of participants ask the PwD if they want to know 
their diagnosis, but only 39% ask the PwD if they can reveal it to 
their family. 18% asked the family if they should reveal the 
diagnosis to the PwD. 
71% of participants provided information about the prognosis 
and progression of AD to the PwD and 94% did to the family. 
Most cited reasons for not informing PwD of this was that they 
did not ask (94%), or the participant was fearful of a depressive 
reaction (71%), or that the knowledge was useless to the PwD 
(29%) 
The most frequent emotional reactions of PwD on hearing the 
diagnosis were depressive reaction (50%), indifference (51%), 
anxiety/nervousness (46.8%) and denial/minimisation (40%). The 
most frequent emotional reaction from family members was 
anxiety (50%). 
80% 
Shimizu et al., 2008: 
Disclosure of the 
diagnosis of Alzheimer’s 
disease 
50 carers of PwD 
and 50 control 
participants who 




To investigate the 
opinion of a Brazilian 
sample of participants on 
the disclosure of an AD 
diagnosis 
90% of carers would want the diagnosis disclosed to them ifs they 
had AD, and 98% of the controls expressed this wish.  
52% of carers and 57% of controls felt that it was the PwD’s right 
to know, and ranked this the top justification for disclosure.  
80% 
Stokes et al., 2014: 
Understanding the 
dementia diagnosis: The 
impact on the caregiving 
experience 
10 spousal carers 
of PwD recruited 
from local 
dementia groups 




interviews using IPA 
To understand how 
caring partners make 
sense of the diagnosis 
and how it impacts their 
experiences as 
caregivers.  
Participants wondered why professionals had not been more 
forthcoming with information and wondered if this was 
deliberate or accidental. Carers expressed a wish for information 
about typical manifestations of dementia and practical 
information about health, social, and financial support.  
Some carers were able to use the medical explanation provided 
as a framework to explain the PwD’s behaviour and changes. 
Others found the medical framework incomplete for 
understanding the condition, and this seemed to occur when 
there was a lack of explanation of the condition.  
100% 
Van-Wijngaarden et al., 
2018: Entangled in 
uncertainty: The 
experience of living with 
dementia from the 









interviews and two 
focus groups (N=6 
and 4) 
To develop an insight 
into what it means to live 
with dementia from the 
perspective of family 
members 
For most participants disclosure of the dementia diagnosis was 
paradoxical in that it provided relief and an explanation of the 
behaviours their loved one had displayed, but left carers in a 
state of uncertainty, with no idea about the course of the disease 
or expectations for the future.  
80% 
perspective of family 
caregivers 
Carers receive a new role at the disclosure of the diagnosis, in an 
instant they go from not being a carer to being a carer, but 
without any education as to what this new role involves. Many 
respondents were annoyed at the lack of information.  
Disclosure took away hope and trust in the future for some 
participants as they associated dementia with a humiliating, 
progressive process involving poor care and social exclusion.  
A small minority of carers preferred to receive the disclosure 
themselves and not tell the PwD.  
Villars et al., 2010: 
The primary care 
physician and AD: An 
international position 
paper 
  Group opinion of a 






To establish the role of 
the primary care 
physician in detection, 
early diagnosis, 
treatment and follow up, 
and in clinical trials of 
dementia 
The disclosure protocol should be a repeated and planned 
announcement where the diagnosis is disclosed by the specialist, 
and again by the PCP to reaffirm.  
PCPs need training opportunities to integrate this disclosure into 
their consultation.  
Disclosure must occur before care planning, and provide basic 
education to the family. Care plans should be presented to avoid 
causing excessive concern to PwD and families about the 
progression of dementia.  
Legal issues such as advance directives, designated people of 
trust and driving can be covered at this time.  
100% 
Vince et al., 2017: 
The meaning and 
experience of well-being 
in dementia for 
psychiatrists involved in 
diagnostic disclosure: a 
qualitative study 
11 Psychiatrists  Three NHS 
Trusts in North 
of England 
Semi-structured 
interviews with IPA 
To explore the meaning 
of living well with 
dementia from the 
perspective of 
psychiatrists and their 




Participants’ understanding of well-being was underpinned by a 
nihilistic and reductionist view of dementia, embedded within the 
medical model that dementia represents a threat to well-being 
directly associated with a decline in functioning.  
Diagnostic disclosure meeting viewed as a key event in a person’s 
life and an opportunity to discuss well-being and engagement 
with services, although some participants felt the shocking nature 
of the disclosure meant that well-being should be addressed at a 
later time point.  
Disclosure is only helpful in supporting well-being if people are 
ready to hear their diagnosis, and that early diagnosis can be 
detrimental to well-being. 
Participants felt that it was right to tailor language even though 
this raised dilemmas for whether to disclose the diagnosis in full 
and explicit terms.  
Participants expressed tensions between positivity and reality, as 
they wanted to provide positive messages that were genuine and 
realistic about the future.  
Participants felt that the diagnosis was a separate part of the 
discussion to well-being.  
Participants described a discrepancy between the care they 
wished to provide and the care they did provide, for example the 
practical and emotional difficulties of disclosing a diagnosis to 
someone with whom they do not have a therapeutic relationship.  
90% 
Visser et al., 2012: 
Disclosure of Alzheimer’s 
disease biomarker status 
  Opinion/commentary Comment on the 
interpretation of 
biomarker scores in 
The authors propose the shared decision making model. 
Physicians should provide information on possible outcomes 
before biomarker testing, and agree with patients whether they 
100% 
in subjects with mild 
cognitive impairment 
people with MCI and 
present an approach to 
disclose them 
want to undertake testing and know the results. The implications 
of different outcomes should be fully explained at disclosure.  
Woods et al., 2018: 
Timely diagnosis of 
dementia? Family carers’ 
experiences in 5 European 
countries 






Survey of informal 
carers’ views 
To examine the carers’ 
experience of the 
diagnostic process, 
disclosure of diagnosis, 
and impact of diagnosis 
over time. 
47% of carers felt the diagnosis was delayed, and contributing 
factors were the PwD refusing to be assessed (38%) and negative 
professional attitudes (33%) where the first professional seen did 
not consider anything wrong and being told there was no point in 
a diagnosis (7%).  
Carer ratings of quality indicators of sharing the diagnosis were 
generally favourable, except for pre-diagnostic counselling (did 
PwD want to know?), for the carer being able to speak to the 
healthcare professional alone, and for having a written summary.  
Higher quality diagnosis sharing was associated with lower 
sadness, depression, and despair, and greater acceptance, 
reassurance both immediately after diagnosis, and beyond 
(average of 4 years).  
100% 
Wynn et al., 2017: 
Discourse features among 
providers, patients, and 
companions, and their 
















Quantify the content of 
diagnostic conversations 
to examine the 
prevalence of different 
types of discourse across 
stakeholders. 
Investigate relationship 
between elements of 
discourse to dementia 
severity and 
psychological outcomes. 
With increasing dementia severity patients spoke less in the 
interaction.  
Providers (Healthcare professionals) spoke most frequently, 
accounting for an average of 73% of the dialogue. 
Patients used Lifestyle/Psychosocial Information and Emotional 
Rapport building features of dialogue more than companions. 
Providers and companions gave more medical/Therapeutic 
information as dementia severity increased.  
More positive rapport building from providers was associated 
with lower depression and anxiety scores for PwD.  
90% 
Xanthopoulou, et al., 
2019: Patient and 
companion concerns 
when receiving a 
dementia diagnosis: an 







UK Video observations 
of disclosure 
meetings 
This study explored 
concerns expressed in 
HCP–patient–companion 
communication in 
specialist memory clinics 
during the dementia 
diagnostic feedback 
meeting. 
Topics of concern for patients and companions included the 
dementia diagnosis itself, symptoms of dementia, impact on 
family, physical health of the patient, frustration with the 
symptoms of dementia, mental health, medication, prognosis, the 
role of the companion, lack of social connection and other. All 
concerns were given a response by the healthcare professional, 
where 62% were encouraged to elaborate and 38% were 
discouraged from elaborating. When concerns were elicited by 
the healthcare professional, they were more likely to respond by 
encouraging elaboration, but comparatively when concerns were 
volunteer by the patient or companion the healthcare 
professional was more likely to respond by discouraging 
elaboration.  
100% 
Zaleta et al., 2010: 
Patient-centred 
communication during 
















concentrated on 15 
patient-centred 
Characterise the extent 
to which physicians 
adopt a patient-centred 
approach in disclosure. 
Evaluate whether 
patient-centred 
behaviours differ in 
The most frequent patient-centred behaviour was positive 
rapport building, in particular physician agreement with 
PwD/companion and showing approval. Facilitation and patient 
activation was the next most frequent category of behaviours, 
with back channelling most commonly used (signalling interest 
with non-lexical utterances), followed by checking their 
understanding, and the PwD/companion’s understanding. 
80% 
physician behaviours 
and looked for 
expressions of 
positive affect.  
relation to patient 
characteristics. 
Physicians asked for PwD/companion opinions, permission, or 
reassurance less frequently. Emotional rapport building was the 
least used category of behaviours and occurred infrequently. 
Physicians rarely offered statements of reassurance or optimism, 
and infrequently expressed concern or worry. Few instances of 
empathy were demonstrated, PwD/companion feelings were 
infrequently legitimised and physicians tended not to self-disclose 
or create a sense of partnership with the PwD/companion.  
There was considerable variation between physicians, but 
physicians were generally consistent in their behaviours within 
themselves.  
Zaleta et al., 2012: 
Agreement about 
diagnosis among patients, 
companions, and 
professionals following a 
dementia evaluation 












from physician, PwD, 
companion, written 
summary from nurse 
present at disclosure, 
& trained raters 
viewing the video. 
PwD & companions 
contacted separately 
by phone and asked 
structured interview. 
Provide a systematic 
evaluation of agreement 
among physicians, PwD, 
companions, and other 
professionals about 
results of diagnostic 
work-up. 
Consensus was moderate but far from perfect, and generally PwD 
had only fair agreement with other sources.  
PwD and companions felt feedback was thorough, suggesting 
self-perceived comprehension was high 
Physicians felt that PwD who agreed with the disclosure 
understood the feedback better than those who did not agree.  
PwD tended to report no dementia when other sources believed 
they had dementia.  
 
80% 
Zou et al., 2017: 
Caregivers' attitude 
toward disclosure of 
Alzheimer's disease 
diagnosis in Urban China 




Urban China Questionnaire study 
of carers of PwD 
Obtain the attitude of 
carers towards disclosure 
of AD to patients 
For carers of PwD who knew the diagnosis, half felt the PwD had 
suffered emotionally from knowing. 
95.7% of carers would want to know themselves if they had 
dementia. 
97.6% of carers would want the diagnosis disclosed to a family 
member if they had dementia. 
Reasons for disclosure included having a right to know, slowing 
the disease, facing the condition positively, know what is 
happening to them, and plan for the future.  
100% 
 




Figure 1: PRISMA flow diagram of included studies 
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 Additional records identified 
through other sources 
(n = 75) 
Records after duplicates removed 
(n = 390) 
Records screened 
(n = 390) 
Records excluded 
(n = 302) 
Full-text articles assessed 
for eligibility 
(n = 88) 
Full-text articles excluded  
(n = 36) 
 Review articles (n = 32) 
 Did not explore diagnosis 
disclosure (n = 4) 
Studies included in 
narrative synthesis 
(n = 52) 
